Brilla Health Cold-Flu Recovery by Hadaf Llc / Santonika Uab 72123-004 Cold-Flu

Brilla Health Cold-Flu Recovery by

Drug Labeling and Warnings

Brilla Health Cold-Flu Recovery by is a Homeopathic medication manufactured, distributed, or labeled by Hadaf Llc, Santonika Uab. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BRILLA HEALTH COLD-FLU RECOVERY- homeopathic tablet 
Hadaf Llc

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

72123-004 Cold-Flu

Active Ingredients

Lapine interferon gamma immune globulin 12C, 30C, 50C Purpose: enchance magnitude of immune response

Lapine histamine immune globulin 12C, 30C, 50C Purpose: reduce histamine and inflammation response

Lapine CD4 immune globulin 12C, 30C, 50C Purpose: Enhance functional activity of immune system

Purpose

Homeopathic,

Enhance magnitude of immune response

Reduce histamine and inflammation response

Enhance functional activity of immune system

Uses

Shorten the duration of flu and cold symptoms
Reduce severity of flu and cold symptoms, including nasal congestion, cough and sore/itchy throat

Warnings

Ask a doctor or pharmacist before use if you are lactose-intolerant.

Stop use and ask a doctor if symptoms persist or worsen.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

A llergic (hypersensitivity) reactions may occur in very rare cases.

Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

Ask a doctor

Ask a doctor or pharmacist before use if you are lactose-intolerant.

Stop use and ask a doctor if symptoms persist or worsen.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergic Reaction

Allergic (hypersensitivity) reactions may occur in very rare cases.

Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

Directions

For adults and children 1 year and older.
Hold tablet in mouth until completely dissolved, without food. If necessary, tablet can be taken dissolved in 1 tablespoon of drinking water.
Day 1: 8 tablets total for the first day
1 tablet every 30 minutes for the first 2 hours
(a total of 5 tablets over 2 hours),
1 tablet taken 3 more times at equal intervals
(a total of 3 tablets over the remainder of the day).
Days 2 to 5: 1 tablet 3 times a day
(at equal intervals).

Other Information

Store in original package below 25°C or 77°F.
Do not use if blister pack is torn or broken.

Inactive Ingredients

Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose.

40 Tablets NDC: 72123-004-01

BRILLA HEALTH COLD-FLU RECOVERY 
homeopathic tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72123-004
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LAPINE INTERFERON GAMMA IMMUNE GLOBULIN (UNII: Q2KS2OI6SA) (LAPINE INTERFERON GAMMA IMMUNE GLOBULIN - UNII:Q2KS2OI6SA)	LAPINE INTERFERON GAMMA IMMUNE GLOBULIN	12 [hp_C]  in 12 [hp_C]
LAPINE HISTAMINE IMMUNE GLOBULIN (UNII: 7U4T47R0DD) (LAPINE HISTAMINE IMMUNE GLOBULIN - UNII:7U4T47R0DD)	LAPINE HISTAMINE IMMUNE GLOBULIN	12 [hp_C]  in 12 [hp_C]
LAPINE CD4 IMMUNE GLOBULIN (UNII: UIF41K6WR9) (LAPINE CD4 IMMUNE GLOBULIN - UNII:UIF41K6WR9)	LAPINE CD4 IMMUNE GLOBULIN	12 [hp_C]  in 12 [hp_C]

Inactive Ingredients
Ingredient Name	Strength
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Product Characteristics
Color	white	Score	score with uneven pieces
Shape	ROUND (round tablets)	Size	9mm
Flavor		Imprint Code	other
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72123-004-01	12 [hp_C] in 1 BLISTER PACK; Type 0: Not a Combination Product	07/31/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved homeopathic		07/31/2020	08/07/2020

Labeler - Hadaf Llc (094114708)

Establishment
Name	Address	ID/FEI	Business Operations
Santonika Uab		520214047	manufacture(72123-004)

Revised: 1/2022

Document Id: d5e1cd0d-294c-2506-e053-2995a90aca07

34390-5

Set id: abc3e33f-0f82-a7ed-e053-2995a90a2862

Version: 4

Effective Time: 20220118